Tag: Cancer: Skin
Some Sun Protection Behaviors Up With History of NMSC
Individuals with previous nonmelanoma skin cancer more often use shade, protective clothing
ASCO: Pembrolizumab Improves Survival in Melanoma
Three-year overall survival rate of 40 percent; median overall survival of 24.4 months
ATS: Aggressive Melanoma Linked to Severe, Untreated Sleep Apnea
Study highlights the importance of diagnosing and treating obstructive sleep apnea
Rapid-Onset Diabetes Described With Anti-PD-1 Treatment
Case report of rapid-onset insulin-dependent diabetes with anti-programmed cell death 1 therapy
Pembrolizumab Active in Patients With Advanced Melanoma
Overall response rate of 33 percent for total population, 45 percent among treatment naive
AACR: Pembrolizumab Effective Against Merkel-Cell Carcinoma
Intravenous medication blocks programmed death 1 (PD-1) immune inhibitory pathway
AACR: Nivolumab Appears to Up Survival in Advanced Melanoma
One-third of study participants lived five years or more after starting treatment
Oral Nicotinamide Safe for Renal Transplant Recipients
Treatment linked to nonsignificant reductions in new non-melanoma skin cancers
AACR: SPF 30 Delays Melanoma in Preclinical Model
Study results suggest scientists can use mice to find better ways to prevent melanoma in humans
Excision Margins Don’t Impact Melanoma Recurrence, Survival
Although, sentinel lymph node involvement is tied to poor prognosis
